ZNF23 and neoplasm: ZNF23 was found to be downregulated in hepatocellular carcinoma [86], ovarian cancer [85,87], endometrial cancer [85], melanoma (Figure 4) [88], as well as in various tumor cell lines (endometrial, liver, glia, neuroblast, ovary) as compared to normal controls [85].